StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Equities research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued on Wednesday. The firm set a “buy” rating on the stock.

Mannatech Trading Up 0.4 %

NASDAQ:MTEX opened at $7.50 on Wednesday. The company has a market capitalization of $14.14 million, a P/E ratio of -8.43 and a beta of 1.17. The stock’s 50 day moving average price is $7.44 and its 200 day moving average price is $7.63. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) EPS for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million for the quarter.

Insider Activity at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the transaction, the director now owns 54,721 shares in the company, valued at $424,087.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 41.50% of the stock is owned by company insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.